| Literature DB >> 30106565 |
Zishuo Cheng1, Jamie VanPelt1, Alexander Bergstrom1, Christopher Bethel2, Andrew Katko1, Callie Miller1, Kelly Mason1, Erin Cumming1, Huan Zhang1, Robert L Kimble1, Sarah Fullington1, Stacey Lowery Bretz1, Jay C Nix3, Robert A Bonomo2,4, David L Tierney1, Richard C Page1, Michael W Crowder1.
Abstract
In an effort to evaluate whether a recently reported putative metallo-β-lactamase (MβL) contains a novel MβL active site, SPS-1 from Sediminispirochaeta smaragdinae was overexpressed, purified, and characterized using spectroscopic and crystallographic studies. Metal analyses demonstrate that recombinant SPS-1 binds nearly 2 equiv of Zn(II), and steady-state kinetic studies show that the enzyme hydrolyzes carbapenems and certain cephalosporins but not β-lactam substrates with bulky substituents at the 6/7 position. Spectroscopic studies of Co(II)-substituted SPS-1 suggest a novel metal center in SPS-1, with a reduced level of spin coupling between the metal ions and a novel Zn1 metal binding site. This site was confirmed with a crystal structure of the enzyme. The structure shows a Zn2 site that is similar to that in NDM-1 and other subclass B1 MβLs; however, the Zn1 metal ion is coordinated by two histidine residues and a water molecule, which is held in position by a hydrogen bond network. The Zn1 metal is displaced nearly 1 Å from the position reported in other MβLs. The structure also shows extended helices above the active site, which create a binding pocket that precludes the binding of substrates with large, bulky substituents at the 6/7 position of β-lactam antibiotics. This study reveals a novel metal binding site in MβLs and suggests that the targeting of metal binding sites in MβLs with inhibitors is now more challenging with the identification of this new MβL.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30106565 PMCID: PMC6314204 DOI: 10.1021/acs.biochem.8b00728
Source DB: PubMed Journal: Biochemistry ISSN: 0006-2960 Impact factor: 3.162